(Q43490943)

English

Synergistic immunosuppressive effect of anti-TNF combined with methotrexate on antibody responses to the 23 valent pneumococcal polysaccharide vaccine

scientific article published on 2 May 2008

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

24 November 2017

Synergistic immunosuppressive effect of anti-TNF combined with methotrexate on antibody responses to the 23 valent pneumococcal polysaccharide vaccine (English)

1 reference

Europe PubMed Central

PubMed publication ID

24 November 2017

0 references

0 references

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

3

1 reference

Europe PubMed Central

PubMed publication ID

24 November 2017

author name string

L B S Gelinck

1

1 reference

Europe PubMed Central

PubMed publication ID

24 November 2017

A E van der Bijl

2

1 reference

Europe PubMed Central

PubMed publication ID

24 November 2017

T W J Huizinga

4

1 reference

Europe PubMed Central

PubMed publication ID

24 November 2017

R A van Hogezand

5

1 reference

Europe PubMed Central

PubMed publication ID

24 November 2017

G T Rijkers

6

1 reference

Europe PubMed Central

PubMed publication ID

24 November 2017

F P Kroon

7

1 reference

Europe PubMed Central

PubMed publication ID

24 November 2017

language of work or name

0 references

publication date

2 May 2008

1 reference

Europe PubMed Central

PubMed publication ID

24 November 2017

1 reference

Europe PubMed Central

PubMed publication ID

24 November 2017

26

1 reference

Europe PubMed Central

PubMed publication ID

24 November 2017

27-28

1 reference

Europe PubMed Central

PubMed publication ID

24 November 2017

3528-3533

1 reference

Europe PubMed Central

PubMed publication ID

24 November 2017

Treatment of rheumatoid arthritis.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.04.028

7 January 2021

Inflammatory Bowel Disease

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.04.028

7 January 2021

Infliximab and methotrexate in the treatment of rheumatoid arthritis. Anti-Tumor Necrosis Factor Trial in Rheumatoid Arthritis with Concomitant Therapy Study Group

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.04.028

7 January 2021

Therapeutic effect of the combination of etanercept and methotrexate compared with each treatment alone in patients with rheumatoid arthritis: double-blind randomised controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.04.028

7 January 2021

The PREMIER study: A multicenter, randomized, double-blind clinical trial of combination therapy with adalimumab plus methotrexate versus methotrexate alone or adalimumab alone in patients with early, aggressive rheumatoid arthritis who had not had

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.04.028

7 January 2021

Updated consensus statement on biological agents, specifically tumour necrosis factor {alpha} (TNF{alpha}) blocking agents and interleukin-1 receptor antagonist (IL-1ra), for the treatment of rheumatic diseases, 2005

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.04.028

7 January 2021

Tuberculosis associated with infliximab, a tumor necrosis factor alpha-neutralizing agent

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.04.028

7 January 2021

Infections in patients with rheumatoid arthritis treated with biologic agents

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.04.028

7 January 2021

Anti-TNF antibody therapy in rheumatoid arthritis and the risk of serious infections and malignancies: systematic review and meta-analysis of rare harmful effects in randomized controlled trials

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.04.028

7 January 2021

Granulomatous infections due to tumor necrosis factor blockade: correction

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.04.028

7 January 2021

Tumor necrosis factor and its blockade in granulomatous infections: differential modes of action of infliximab and etanercept?

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.04.028

7 January 2021

Severe pneumococcal pneumonia following treatment with infliximab for Crohn's disease

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.04.028

7 January 2021

Infections during tumour necrosis factor-alpha blocker therapy for rheumatic diseases in daily practice: a systematic retrospective study of 709 patients

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.04.028

7 January 2021

Serious bacterial infections in patients with rheumatoid arthritis under anti-TNF-alpha therapy

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.04.028

7 January 2021

Guideline for anti-TNF-alpha therapy in psoriatic arthritis

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.04.028

7 January 2021

Guidelines for immunizations in patients with inflammatory bowel disease

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.04.028

7 January 2021

The effect of anti-tumour necrosis factor alpha treatment on the antibody response to influenza vaccination

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.04.028

7 January 2021

The effect of tumor necrosis factor blockade on the response to pneumococcal vaccination in patients with rheumatoid arthritis and ankylosing spondylitis.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.04.028

7 January 2021

Influence of methotrexate, TNF blockers and prednisolone on antibody responses to pneumococcal polysaccharide vaccine in patients with rheumatoid arthritis.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.04.028

7 January 2021

Pneumococcal vaccination for RA patients on TNF-alpha antagonists

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.04.028

7 January 2021

Immunoglobulin isotype-specific antibody responses to pneumococcal polysaccharide vaccine in patients with recurrent bacterial respiratory tract infections

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.04.028

7 January 2021

Antibodies against pneumococcal polysaccharides after vaccination in HIV-infected individuals: 5-year follow-up of antibody concentrations

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.04.028

7 January 2021

Antibody response to influenza, tetanus and pneumococcal vaccines in HIV-seropositive individuals in relation to the number of CD4+ lymphocytes

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.04.028

7 January 2021

Distinct profiles of human B cell effector cytokines: a role in immune regulation?

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.04.028

7 January 2021

Immunoglobulin levels in methotrexate treated paediatric rheumatology patients

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.04.028

7 January 2021

The 2005 International Symposium on Advances in Targeted Therapies: what have we learned in the 2000s and where are we going?

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.04.028

7 January 2021

Regulation of human B cell function by sulfasalazine and its metabolites

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.04.028

7 January 2021

Efficacy of selective B cell blockade in the treatment of rheumatoid arthritis: evidence for a pathogenetic role of B cells

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.04.028

7 January 2021

Rituximab for rheumatoid arthritis refractory to anti-tumor necrosis factor therapy: Results of a multicenter, randomized, double-blind, placebo-controlled, phase III trial evaluating primary efficacy and safety at twenty-four weeks

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.04.028

7 January 2021

Vaccinate your immunocompromised patients!

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.04.028

7 January 2021

Audit on the uptake of influenza and pneumococcal vaccination in patients with rheumatoid arthritis

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.04.028

7 January 2021

Identifiers

10.1016/J.VACCINE.2008.04.028

1 reference

Europe PubMed Central

PubMed publication ID

24 November 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

24 November 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q43490943&oldid=1989879298"